Very Common Non-Alcoholic Fatty Liver Disease
Échec de l'ajout au panier.
Échec de l'ajout à la liste d'envies.
Échec de la suppression de la liste d’envies.
Échec du suivi du balado
Ne plus suivre le balado a échoué
Acheter pour 5,22 $
Aucun mode de paiement valide enregistré.
Nous sommes désolés. Nous ne pouvons vendre ce titre avec ce mode de paiement
-
Narrateur(s):
-
Paul Hampson
-
Auteur(s):
-
James M. Lowrance
À propos de cet audio
Most of the general population is not well informed about a common condition affecting the liver, that affects an estimated 29 million people in America alone. Up to 6.5 million of these people, will go on to experience inflammation in their livers or what is also referred to as "steatohepatitis."
Many will eventually experience cirrhosis in their livers, meaning scarring/lesions that will begin to appear within the organ, which is irreversible and that can eventually lead to death or in the need for a life-saving liver transplant. The author whose words you are listening to in this audiobook, is a patient who has lived with a condition of non-alcoholic fatty liver, since the year 2007 (for six years at the time of writing).
My case of the disease has not gone on to become steatohepatitis but I have been diagnosed with enlargement of my liver, which is reversible at this point, if I follow my doctor's treatments and a weight loss plan (my obesity is between moderate and severe). While I am not a medical professional, I am one who can relate facts concerning this disease, from firsthand experience with it. I can also pass along the knowledge I have accrued, through six years of extensive research on literally hundreds of reputable medical websites, as well as from blogs and articles written by fellow liver disease patients.
While the information I will relate is not as extensive as that one could contain through a professional medical journal, I do believe I can express information that most laypersons would be seeking, in addition to sharing my personal experience with this potentially very serious disease.
©2013 James M. Lowrance (P)2013 James M. Lowrance